BioNTech SE (BNTX) Share-based Compensation (2018 - 2026)

BioNTech SE has reported Share-based Compensation for 7 years, with the latest figure at $28.1 million in Q4 2025.

• Quarterly Share-based Compensation rose 11.71% year-over-year to $28.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $120.3 million (up 9.83% YoY) and the FY2025 annual result came in at $120.0 million, up 11.28% from the prior year.
• Share-based Compensation slipped to $28.1 million in Q4 2025 per BNTX's latest filing, from $32.6 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $73.6 million in Q3 2021 and troughed at $20.87 in Q1 2021.
• A 5-year average of $26.1 million and a median of $22.9 million in 2022 frame the typical range for Share-based Compensation.
• The widest YoY moves for Share-based Compensation: up 269441191.15% in 2021, down 100.0% in 2021.
• Over 5 years, Share-based Compensation stood at $23.5 million in 2021, then slipped by 3.42% to $22.6 million in 2022, then slumped by 32.54% to $15.3 million in 2023, then jumped by 64.36% to $25.1 million in 2024, then grew by 11.71% to $28.1 million in 2025.
• According to Business Quant data, Share-based Compensation over the past three periods registered $28.1 million, $32.6 million, and $36.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.